Skip to main content
Erschienen in: Basic Research in Cardiology 5/2010

01.09.2010 | Original Contribution

TGF-β1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes

verfasst von: Sibylle Wenzel, Kirsten Henning, Andreas Habbig, Svenja Forst, Rolf Schreckenberg, Jacqueline Heger, Hagen Maxeiner, Klaus-Dieter Schlüter

Erschienen in: Basic Research in Cardiology | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

TGF-β1 plays an important role in cardiac fibrosis, apoptosis, induction of hypertrophy and contractile dysfunction. This study investigates whether TGF-β1 plays a role in laminin receptor 37/67 (37/67 LR)-dependent regulation of cardiac performance. Therefore, isolated adult cardiomyocytes were stimulated with TGF-β1, the expression of the 37/67 LR was determined and cell shortening was investigated on cells attached to a non-specific, serum-based attachment substrate or to specific, laminin-coated dishes. The role of the MAP kinases in TGF-β1-dependent induction of the 37/67 LR was examined by addition of PD98059, SB202190 and SP600125. Finally, the expression of receptor mRNA was investigated in transgenic mice constitutively over-expressing TGF-β1 and the relationship to distress score and lung wet weight-to-body weight was analysed. TGF-β1 induced a significant increase of the 37/67 LR mRNA and protein expression. The cytokine induced p38 MAP kinase and JNK, but not ERK. Inhibition of either p38 MAP kinase or JNK attenuated the TGF-β1-dependent increase in 37/67 LR expression. TGF-β1 induced a loss of cell shortening in cells attached to a non-specific substrate, but not in cells on a pre-coated laminin matrix. Inhibition of JNK attenuated the protective effect of laminin receptor up-regulation on cardiac performance. Inhibition of p38 MAP kinase attenuated the depressive effect of TGF-β1 on basal cell shortening. In transgenic mice over-expressing TGF-β1 a strong induction of laminin receptor expression attenuated the severeness of the mice’ symptoms. This study shows a new and protective role of TGF-β1-dependent up-regulation of the 37/67 LR in cardiomyocytes in cardiac remodelling with increased laminin expression.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Boluyt MO, Bing OH, Lakatta EG (1995) The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur Heart J 16(Suppl N):19–30PubMed Boluyt MO, Bing OH, Lakatta EG (1995) The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur Heart J 16(Suppl N):19–30PubMed
2.
Zurück zum Zitat Dubus I, Rappaport L, Barrieux A, Lompre AM, Schwartz K, Samuel JL (1993) Contractile protein gene expression in serum-free cultured adult rat cardiac myocytes. Pflugers Arch 423:455–461CrossRefPubMed Dubus I, Rappaport L, Barrieux A, Lompre AM, Schwartz K, Samuel JL (1993) Contractile protein gene expression in serum-free cultured adult rat cardiac myocytes. Pflugers Arch 423:455–461CrossRefPubMed
3.
Zurück zum Zitat Frantz S, Behr T, Hu K, Fraccarollo D, Strotmann J, Goldberg E, Ertl G, Angermann CE, Bauersachs J (2007) Role of p38 mitogen-activated protein kinase in cardiac remodelling. Br J Pharmacol 150:130–135CrossRefPubMed Frantz S, Behr T, Hu K, Fraccarollo D, Strotmann J, Goldberg E, Ertl G, Angermann CE, Bauersachs J (2007) Role of p38 mitogen-activated protein kinase in cardiac remodelling. Br J Pharmacol 150:130–135CrossRefPubMed
4.
Zurück zum Zitat Frantz S, Hu K, Adamek A, Wolf J, Sallam A, Maier SK, Lonning S, Ling H, Ertl G, Bauersachs J (2008) Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol 103:485–492CrossRefPubMed Frantz S, Hu K, Adamek A, Wolf J, Sallam A, Maier SK, Lonning S, Ling H, Ertl G, Bauersachs J (2008) Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol 103:485–492CrossRefPubMed
5.
Zurück zum Zitat Gloe T, Pohl U (2002) Laminin binding conveys mechanosensing in endothelial cells. News Physiol Sci 17:166–169PubMed Gloe T, Pohl U (2002) Laminin binding conveys mechanosensing in endothelial cells. News Physiol Sci 17:166–169PubMed
6.
Zurück zum Zitat Hao GH, Niu XL, Gao DF, Wei J, Wang NP (2008) Agonists at ppar-gamma suppress angiotensin ii-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. Br J Pharmacol 153:1409–1419CrossRefPubMed Hao GH, Niu XL, Gao DF, Wei J, Wang NP (2008) Agonists at ppar-gamma suppress angiotensin ii-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. Br J Pharmacol 153:1409–1419CrossRefPubMed
7.
Zurück zum Zitat Klein G, Schaefer A, Hilfiker-Kleiner D, Oppermann D, Shukla P, Quint A, Podewski E, Hilfiker A, Schroder F, Leitges M, Drexler H (2005) Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ Res 96:748–755CrossRefPubMed Klein G, Schaefer A, Hilfiker-Kleiner D, Oppermann D, Shukla P, Quint A, Podewski E, Hilfiker A, Schroder F, Leitges M, Drexler H (2005) Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ Res 96:748–755CrossRefPubMed
8.
Zurück zum Zitat Larson DF, Ingham R, Alwardt CM, Yang B (2004) Tgf-Beta1 overexpression: a mechanism of diastolic filling dysfunction in the aged population. J Extra Corpor Technol 36:69–74PubMed Larson DF, Ingham R, Alwardt CM, Yang B (2004) Tgf-Beta1 overexpression: a mechanism of diastolic filling dysfunction in the aged population. J Extra Corpor Technol 36:69–74PubMed
9.
Zurück zum Zitat Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-i in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874–881PubMed Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-i in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874–881PubMed
10.
Zurück zum Zitat Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71:418–435CrossRefPubMed Lijnen PJ, Petrov VV, Fagard RH (2000) Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 71:418–435CrossRefPubMed
11.
Zurück zum Zitat Mufti S, Wenzel S, Euler G, Piper HM, Schlüter KD (2008) Angiotensin ii-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect. J Cell Physiol 217:242–249CrossRefPubMed Mufti S, Wenzel S, Euler G, Piper HM, Schlüter KD (2008) Angiotensin ii-dependent loss of cardiac function: mechanisms and pharmacological targets attenuating this effect. J Cell Physiol 217:242–249CrossRefPubMed
12.
Zurück zum Zitat Ramirez MT, Sah VP, Zhao XL, Hunter JJ, Chien KR, Brown JH (1997) The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem 272:14057–14061CrossRefPubMed Ramirez MT, Sah VP, Zhao XL, Hunter JJ, Chien KR, Brown JH (1997) The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem 272:14057–14061CrossRefPubMed
13.
Zurück zum Zitat Ruf S, Piper M, Schluter KD (2002) Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro. Pflugers Arch 443:483–490CrossRefPubMed Ruf S, Piper M, Schluter KD (2002) Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro. Pflugers Arch 443:483–490CrossRefPubMed
14.
Zurück zum Zitat Sadoshima J, Montagne O, Wang Q, Yang G, Warden J, Liu J, Takagi G, Karoor V, Hong C, Johnson GL, DE Vatner, Vatner SF (2002) The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest 110:271–279PubMed Sadoshima J, Montagne O, Wang Q, Yang G, Warden J, Liu J, Takagi G, Karoor V, Hong C, Johnson GL, DE Vatner, Vatner SF (2002) The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest 110:271–279PubMed
15.
Zurück zum Zitat Sakata Y, Chancey AL, Divakaran VG, Sekiguchi K, Sivasubramanian N, Mann DL (2008) Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol 103:60–68CrossRefPubMed Sakata Y, Chancey AL, Divakaran VG, Sekiguchi K, Sivasubramanian N, Mann DL (2008) Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor. Basic Res Cardiol 103:60–68CrossRefPubMed
16.
Zurück zum Zitat Schluter KD, Schreiber D (2005) Adult ventricular cardiomyocytes: isolation and culture. Methods Mol Biol 290:305–314PubMed Schluter KD, Schreiber D (2005) Adult ventricular cardiomyocytes: isolation and culture. Methods Mol Biol 290:305–314PubMed
17.
Zurück zum Zitat Schluter KD, Simm A, Schafer M, Taimor G, Piper HM (1999) Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am J Physiol 276:H1655–H1663PubMed Schluter KD, Simm A, Schafer M, Taimor G, Piper HM (1999) Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am J Physiol 276:H1655–H1663PubMed
18.
Zurück zum Zitat Schroder D, Heger J, Piper HM, Euler G (2006) Angiotensin II stimulates apoptosis via tgf-beta1 signaling in ventricular cardiomyocytes of rat. J Mol Med 84:975–983CrossRefPubMed Schroder D, Heger J, Piper HM, Euler G (2006) Angiotensin II stimulates apoptosis via tgf-beta1 signaling in ventricular cardiomyocytes of rat. J Mol Med 84:975–983CrossRefPubMed
19.
Zurück zum Zitat See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H (2004) P38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 44:1679–1689CrossRefPubMed See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H (2004) P38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 44:1679–1689CrossRefPubMed
20.
Zurück zum Zitat Seeland U, Haeuseler C, Hinrichs R, Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K, Bohm M (2002) Myocardial fibrosis in transforming growth factor-beta(1) (tgf-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest 32:295–303CrossRefPubMed Seeland U, Haeuseler C, Hinrichs R, Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K, Bohm M (2002) Myocardial fibrosis in transforming growth factor-beta(1) (tgf-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest 32:295–303CrossRefPubMed
21.
Zurück zum Zitat Singal T, Dhalla NS, Tappia PS (2009) Regulation of c-fos and c-jun gene expression by phospholipase C activity in adult cardiomyocytes. Mol Cell Biochem 327:229–239CrossRefPubMed Singal T, Dhalla NS, Tappia PS (2009) Regulation of c-fos and c-jun gene expression by phospholipase C activity in adult cardiomyocytes. Mol Cell Biochem 327:229–239CrossRefPubMed
22.
Zurück zum Zitat Tomy PM, Anilkumar NP, Sudhakaran PR (1994) Multiple laminin binding proteins in human fetal heart. Dev Growth Differ 36:333–340CrossRef Tomy PM, Anilkumar NP, Sudhakaran PR (1994) Multiple laminin binding proteins in human fetal heart. Dev Growth Differ 36:333–340CrossRef
23.
Zurück zum Zitat Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103:319–327CrossRefPubMed Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103:319–327CrossRefPubMed
24.
Zurück zum Zitat Wenzel S, Abdallah Y, Helmig S, Schäfer C, Piper HM, Schlüter KD (2006) Contribution of PI 3-kinase isoforms to angiotensin II- and alpha-adrenoceptor-mediated signalling pathways in cardiomyocytes. Cardiovasc Res 71:352–362CrossRefPubMed Wenzel S, Abdallah Y, Helmig S, Schäfer C, Piper HM, Schlüter KD (2006) Contribution of PI 3-kinase isoforms to angiotensin II- and alpha-adrenoceptor-mediated signalling pathways in cardiomyocytes. Cardiovasc Res 71:352–362CrossRefPubMed
25.
Zurück zum Zitat Wenzel S, Soltanpour G, Schlüter KD (2005) No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function. Pflugers Arch 451:328–337CrossRefPubMed Wenzel S, Soltanpour G, Schlüter KD (2005) No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function. Pflugers Arch 451:328–337CrossRefPubMed
26.
Zurück zum Zitat Xiao H, Zhang YY (2008) Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models. Clin Exp Pharmacol Physiol 35:335–341CrossRefPubMed Xiao H, Zhang YY (2008) Understanding the role of transforming growth factor-beta signalling in the heart: overview of studies using genetic mouse models. Clin Exp Pharmacol Physiol 35:335–341CrossRefPubMed
Metadaten
Titel
TGF-β1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes
verfasst von
Sibylle Wenzel
Kirsten Henning
Andreas Habbig
Svenja Forst
Rolf Schreckenberg
Jacqueline Heger
Hagen Maxeiner
Klaus-Dieter Schlüter
Publikationsdatum
01.09.2010
Verlag
Springer-Verlag
Erschienen in
Basic Research in Cardiology / Ausgabe 5/2010
Print ISSN: 0300-8428
Elektronische ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-010-0108-1

Weitere Artikel der Ausgabe 5/2010

Basic Research in Cardiology 5/2010 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.